LUCA Science and Kyowa Kirin Announce Joint Research Agreement on Mitochondrial Disease Treatment With Novel Mitochondria Modality

TOKYO–(BUSINESS WIRE)–LUCA Science Inc. (LUCA Science, Tokyo, Japan) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, Tokyo, Japan, TSE:4151) are pleased to announce they have entered into a research collaboration agreement on the treatment of mitochondrial diseases using platform of an innovative mitochondrial modality. Through this research collaboration, Kyowa Kirin, a leading specialty pharmaceutical company with … [Read more…]

Collecting Sensitive Data Without User Consent: 10 Major Dutch Online Pharmacies Violate GDPR Requirements – Usercentrics Reports

MUNICH–(BUSINESS WIRE)–Analysis by Usercentrics shows: 10 major Dutch online pharmacies violate GDPR requirements by setting an average number of 23 non-necessary cookies without any user consent. Within the EU 89% of the most significant online pharmacies do not meet GDPR requirements. Pharmacy webshops constantly process personal data of their visitors and customers, while selling privacy-sensitive … [Read more…]

Collecting Sensitive Data Without User Consent: 24 Leading Online Pharmacies From Nordic Countries Fail GDPR Requirements – Usercentrics Reports

MUNICH–(BUSINESS WIRE)–Analysis by Usercentrics shows: Over 80% of scanned domains from Denmark, Sweden and Norway are not GDPR compliant, setting at least one non-necessary cookie without user consent. Sweden ranks highest with an average of 26 non-necessary cookies set. In total 89% of the most popular online pharmacies in the EU do not meet GDPR … [Read more…]

Lysogene Provides Clinical Update on AAVance Phase 2/3 Clinical Trial with Gene Therapy LYS-SAF302 for the Treatment of MPS IIIA at the 25th Annual ASGCT Meeting

Promising efficacy data in young patients with persistent increase or stabilization in 3 main developmental domains (cognition, motor and language) in all patients enrolled under the age of 30 months Final and comprehensive results of the 24 months pivotal data for the main cohort are expected in Q3 2022 along with the results of the … [Read more…]

Freudenberg Medical Launches HelixFlex™ TPE Tubing for Bioprocessing Applications at Pharmapack 2022

KAISERSLAUTERN, Germany–(BUSINESS WIRE)–Freudenberg Medical, a manufacturer of medical and pharmaceutical devices, components and tubing, has introduced HelixFlex™, a high purity thermoplastic elastomer TPE tubing designed for use in pharmaceutical and biopharmaceutical applications. This is an expanded offering from Freudenberg, adding to its existing pharma product portfolio of silicone tubing and fluid transfer products for bioprocessing, … [Read more…]

Anterra Capital: Pandemic and Food Price Inflation Fuel Investor Interest to Accelerate Transformation of the Food and Ag Sector

Anterra Capital’s second Global Food and Agriculture Technology Fund closes at $260 million, oversubscribed thanks to robust institutional demand AMSTERDAM & BOSTON–(BUSINESS WIRE)–A crushing pandemic and, more recently, the Ukraine war have convinced investors more than ever that the world needs to radically change how it produces, distributes and consumes food, says Adam Anders, managing … [Read more…]

“Everyday Japan Expo” Melo Became Brand New Sterilized Retail Shop in Singapore.

Setting Higher Standard of Safety & Comfort to our customers in Singapore from Melo! @Funan Mall SINGAPORE–(BUSINESS WIRE)–During Post-Covid regime in Singapore, with Innovation & Technology from Japan, now Melo, managed by Global Partners Consulting Group (HQ: Singapore; Managing Director: Zenta Nishida), is introducing the brand-new sterilized retail shop in Singapore to ensure its customers … [Read more…]

AHF Protest: Gilead Destroys Rx Safety Net for Greater Profits

Gilead Protest, Wednesday, May 18th, 12:00 pm Foster City, CA In March, Gilead imposed conditions illegally restricting access on 340B drug pricing to its branded hepatitis C treatments when covered entities use outside contract pharmacies. Gilead has the ignominious distinction of being the 15th manufacturer to place similar unlawful restrictions on certain 340B contract pharmacy … [Read more…]

City of Hope and Imugene Announce First Patient Dosed in Phase 1 Trial to Test Cancer-Killing Oncolytic Virus Against Solid Tumors

City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumors. SYDNEY & LOS ANGELES–(BUSINESS WIRE)–Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed … [Read more…]

CORRECTING and REPLACING Linear Health Sciences Announces U.S. FDA Clearance and Health Canada Approval of Its Orchid Safety Release Valve (SRV)

Device Intended to Reduce Risk of IV Catheter Failure and Replacement in Hospitals; Sister Product Orchid SRV-Type D for Drainage to Launch Simultaneously OKLAHOMA CITY–(BUSINESS WIRE)–#FDA–Please replace the release with the following corrected version due to the removal of paragraph eight (“Linear Health Sciences won an Innovative Technology Award for Orchid SRV from Vizient, and … [Read more…]